RNS Number : 1454V
Legal & General UCITS ETF PLC
04 August 2020
| Funds |
Date |
ISIN code |
Shares in Issue |
Currency |
Net Asset Value |
NAV/per share Base |
| L&G US Equity UCITS ETF |
04/08/2020 |
IE00BFXR5Q31 |
12547267 |
USD |
156846129.71 |
12.500 |
| L&G UK Equity UCITS ETF |
04/08/2020 |
IE00BFXR5R48 |
1200000 |
GBP |
10711691.90 |
8.926 |
| L&G Global Equity UCITS ETF |
04/08/2020 |
IE00BFXR5S54 |
2900000 |
USD |
34581018.91 |
11.924 |
| L&G Japan Equity UCITS ETF |
04/08/2020 |
IE00BFXR5T61 |
11185000 |
USD |
118653315.64 |
10.608 |
| L&G Europe ex UK Equity UCITS ETF |
04/08/2020 |
IE00BFXR5V83 |
9360988 |
EUR |
101291889.45 |
10.821 |
| L&G Asia Pacific ex Japan Equity UCITS ETF |
04/08/2020 |
IE00BFXR5W90 |
5181427 |
USD |
55570957.92 |
10.725 |
| L&G Clean Water UCITS ETF |
04/08/2020 |
IE00BK5BC891 |
1500000 |
USD |
16454216.34 |
10.969 |
| L&G Artificial Intelligence UCITS ETF |
04/08/2020 |
IE00BK5BCD43 |
7946000 |
USD |
111551103.31 |
14.039 |
| L&G Healthcare Innovation UCITS ETF |
04/08/2020 |
IE00BK5BC677 |
3000000 |
USD |
42282505.84 |
14.094 |
| L&G Pharma Breakthrough UCITS ETF |
04/08/2020 |
IE00BF0H7608 |
2150000 |
USD |
26402188.26 |
12.280 |
| L&G Europe Equity (Responsible Exclusions) UCITS ETF |
04/08/2020 |
IE00BKLTRN76 |
9600000 |
EUR |
98162465.88 |
10.225 |
| L&G US Equity (Responsible Exclusions) UCITS ETF |
04/08/2020 |
IE00BKLWY790 |
57800000 |
USD |
653089896.96 |
11.299 |
| L&G Battery Value-Chain UCITS ETF |
04/08/2020 |
IE00BF0M2Z96 |
13200000 |
USD |
138080508.01 |
10.461 |
| L&G Ecommerce Logistics UCITS ETF |
04/08/2020 |
IE00BF0M6N54 |
9600000 |
USD |
111704434.90 |
11.636 |
| L&G ROBO Global Robotics and Automation UCITS ETF |
04/08/2020 |
IE00BMW3QX54 |
46630616 |
USD |
866219896.59 |
18.576 |
| L&G Cyber Security UCITS ETF |
04/08/2020 |
IE00BYPLS672 |
82611776 |
USD |
1710127560.59 |
20.701 |
|
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
[email protected] or visit
www.rns.com.
END
NAVZZGGRZDVGGZZ
